Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Drug-eluting Stent
100%
Chemotherapy Delivery
100%
Chemotherapy
100%
Targeted Chemotherapy
100%
Liver Cancer
66%
Biomaterials
66%
Drug Release
66%
Drug Capture
66%
Small Molecules
66%
Phase I Trial
66%
Patient Quality of Life
66%
Oncology
66%
FDA-approved Drugs
66%
Clinical Trials
33%
Stent Placement
33%
Promising Treatment
33%
Venous Outflow
33%
Drug Toxicity
33%
Effective Management
33%
Rabbit Model
33%
Thrombotic
33%
Pulmonary Vein
33%
Systemic Side Effects
33%
Catheter-related
33%
Successful Development
33%
Systemic Toxicity
33%
Breast Cancer
33%
Anticancer Drugs
33%
Dual Blood Supply
33%
Lung Cancer
33%
Transformative Technology
33%
DNA Target
33%
Doxorubicin
33%
Cancer Patients
33%
Pelvic Tumor
33%
Successful Completion
33%
Interleukin-2
33%
High Dose
33%
Thrombolytic Therapy
33%
Rat Animal Model
33%
Tumor Site
33%
Rich Experience
33%
Platform Technology
33%
Preventive Management
33%
Localized Chemotherapy
33%
Side Effect Management
33%
Treatment Regimen
33%
Chemotherapy Side Effects
33%
Overall Survival
33%
Toxic Drugs
33%
In Vivo Applications
33%
Tumor
33%
Bronchial Artery
33%
Internal Iliac Vein
33%
Liver Angiography
33%
Treatment Options
33%
Internal Mammary Vein
33%
Liver
33%
Liver Vasculature
33%
Medicine and Dentistry
Chemotherapy
100%
Drug-Eluting Stent
50%
Phase I Trials
33%
Liver Cancer
33%
Quality of Life
33%
Biocompatible Material
33%
Side Effect
33%
Oncology
33%
Neoplasm
33%
Fibrinolytic Therapy
16%
Bronchial Artery
16%
Pelvic Tumor
16%
Hope
16%
Immunosuppressant
16%
Pulmonary Vein
16%
Liver Angiography
16%
Vein Blood Flow
16%
Malignant Neoplasm
16%
Breast Cancer
16%
Iliac Vein
16%
Antithrombotic
16%
Liver Circulation
16%
Treatment Option
16%
Interleukin 2
16%
Drug Toxicity
16%
Anticarcinogen
16%
Doxorubicin
16%
Lung Cancer
16%
Cancer
16%
Clinical Trial
16%
Overall Survival
16%
Vascularity
16%
Gene Targeting
16%
Diseases
16%
Stent Placement
16%
Drug Megadose
16%
Cost Efficiency
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy Regimens
100%
Phase I Trials
33%
Drug Release
33%
Liver Cancer
33%
Side Effect
33%
Leporidae
33%
Neoplasm
33%
Gene Delivery
16%
Pelvis Tumor
16%
Anticoagulant Agent
16%
Clinical Trial
16%
Interleukin 2
16%
Immunosuppressive Agent
16%
Fibrinolytic Agent
16%
Drug Toxicity
16%
Breast Cancer
16%
Overall Survival
16%
Malignant Neoplasm
16%
Lung Cancer
16%
Anticarcinogen
16%
Doxorubicin
16%
Rat
16%
Diseases
16%
Biomaterial
8%